Signet Management USA’s AbbVie ABBV Stock Holding History

Signet Management USA’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$36K	Buy	+685	New	+$33.7K	0.02%	137

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Signet Management USA's ABBV Position: Q4 2013 in Review

Signet Management USA opened a new position in AbbVie (ABBV) in Q4 2013: 685 shares worth $36K. The stake represents 0.02% of the portfolio and ranks #137 among its holdings.

1,433 funds tracked by Wall St. Rank hold ABBV as of Q4 2013.

Signet Management USA held 685 shares of AbbVie worth $36K as of Q4 2013.
AbbVie was a new Signet Management USA position in Q4 2013.
AbbVie made up 0.02% of Signet Management USA's portfolio in Q4 2013, its #137 holding.
1,433 funds tracked by Wall St. Rank held AbbVie as of Q4 2013.

Based on Signet Management USA's 13F filing for Q4 2013, filed 11 Feb 2014.